{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:31:26Z","timestamp":1790631086752,"version":"4.1.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 59-year-old man underwent radical prostatectomy for adenocarcinoma in 2009. Because of the progression of PSA levels, a <jats:sup>68<\/jats:sup>Ga-PSMA PET\/CT scan was performed in January 2020. A suspicious uptake was detected in the left cerebellar hemisphere, and there was no evidence of distant metastatic disease other than recurrent malignancy in the prostatectomy bed. MRI revealed a meningioma located in the left cerebellopontine angle. Although PSMA uptake of the lesion increased in the first imaging after hormone therapy, partial regression was noted after radiotherapy applied to this region.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004650","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T23:01:07Z","timestamp":1680735667000},"page":"507-509","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Incidental Meningioma With Altered PSMA Expression After Systemic Hormone Therapy and Local Radiotherapy Detected by 68Ga-PSMA PET\/CT"],"prefix":"10.1097","volume":"48","author":[{"given":"Fatih","family":"Tamer","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Training and Research Hospital, Nigde Omer Halisdemir University, Ni\u011fde"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Omur","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Medical Faculty, Ege University, \u0130zmir, T\u00fcrkiye."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,4,5]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1007\/s00259-017-3780-7","article-title":"Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging","volume":"44","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1097\/RLU.0000000000001451","article-title":"Diagnostic value of 68Ga PSMA-11 PET\/CT imaging of brain tumors-preliminary analysis","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2176\/nmc.cr2012-0417","article-title":"Progression of intracranial meningioma during luteinizing hormone-releasing hormone agonist treatment for prostate cancer: case report","volume":"54","year":"2014","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/pcan.2013.45","article-title":"Emerging association between androgen deprivation therapy and male meningioma: significant expression of luteinizing hormone-releasing hormone receptor in male meningioma","volume":"16","year":"2013","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"bib5-20250621","first-page":"79","article-title":"All that glitters is not prostate cancer: incidental finding of PSMA-avid meningioma","volume":"23","year":"2020","journal-title":"Hell J Nucl Med"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/RLU.0000000000003394","article-title":"68Ga-prostate-specific membrane antigen PET\/CT uptake in intraventricular meningioma in the choroid plexus","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/RLU.0000000000001406","article-title":"Incidental meningioma mimicking metastasis of prostate adenocarcinoma in 68Ga-labeled PSMA ligand PET\/CT","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/RLU.0000000000003172","article-title":"Prostate-specific membrane antigen-avid meningioma detected in 68Ga-prostate-specific membrane antigen PET\/CT","volume":"45","year":"2020","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004650","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:01:36Z","timestamp":1750532496000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,5]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004650","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,5]]}}}